Sign in
CompletedNo phase

Micro and Macro Circulation in Sepsis

Key facts

Who runs it
Denver Health and Hospital Authority
Where
Denver, United StatesSee the site
Trial code
Status
Completed
People taking part
68 people enrolled
Started
1 Jul 2022
Ended
31 May 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Starling Stroke Volume (Starling SV)- Passive Leg Raise
  • Microscan Sublingual Microscopy
  • Venous Excess Ultrasound Scoring (VExUS)
  • Urine Collection
Record updated
5 December 2025

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Septic Patient Cohort:
  • Greater than or equal to 18 years of age
  • Diagnosed with sepsis or septic shock
  • Require admission to the Hospital; Control Cohort:
  • Greater than or equal to 18 years of age
  • Undergoing elective surgery requiring intubation and general anesthesia

Who cannot take part

  • Chronic Kidney disease on dialysis
  • History of Chronic Kidney disease on dialysis, uncontrolled diabetes, cirrhosis, heart failure, or nephritic or nephrotic syndromes
  • Less than 18 years old
  • Less than 18 years old
  • Patients with any of the following characteristics will be excluded
  • Currently pregnant
  • Incarcerated persons; Control Cohort:
  • Currently pregnant
  • Incarcerated persons

Where in United States

  • Denver Health Medical CenterDenver, United States

About the trial

What the trial wants to find out

Purpose: To assess the prognostic role of Handheld Vital Microscopy (HVM) and evaluate levels of endothelial glycocalyx (eGC) breakdown in patients demonstrating Hemodynamic Incoherence (HI), to elucidate a mechanistic link between the eGC and HI in order to inform prognostic enrichment of future resuscitation trials. We will serially evaluate microhemodynamics (MiH) and macro hemodynamics (maH) and the perfused boundary region (PBR, an visual proxy for eGC thickness) using HVM, and a validated circulating biomarker of eGC integrity.

The 2 groups in the trial

  • Septic Patient InterventionsOther group

    Septic Patients will have all interventions performed: Urine collection, Passive Leg Raise, Ultrasound and sublingual microscopy

    Treatment: Starling Stroke Volume (Starling SV)- Passive Leg Raise, Microscan Sublingual Microscopy, Venous Excess Ultrasound Scoring (VExUS), and Urine Collection

  • Control Patient InterventionsOther group

    Control patients will have urine collection and sublingual microscopy performed when intubated

    Treatment: Starling Stroke Volume (Starling SV)- Passive Leg Raise and Urine Collection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Utility of Longitudinal Measurement of Hemodynamic Incoherence and Endothelial
Record updated
5 December 2025